DBV Technologies | Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
Acadia Pharmaceuticals USD 847.02M 85.02M 2025-09
Alnylam Pharmaceuticals USD 1.49B 376.56M 2025-09
Amarin USD 122.8M 25.08M 2025-09
BioMarin Pharmaceutical USD 1.25B 36.29M 2025-09
DBV Technologies USD 69.84M 33.37M 2025-09
Halozyme Therapeutics USD 419.66M 357.8M 2025-09
Incyte USD 2.93B 508.08M 2025-09
Insmed USD 334.76M 949.56M 2025-09
Ionis Pharmaceuticals USD 2.24B 1.94B 2025-09
Neurocrine Biosciences USD 340.2M 76.2M 2025-09
PTC Therapeutics USD 672.62M 344.77M 2025-09
Sarepta Therapeutics USD 613.08M 102.48M 2025-09
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
United Therapeutics USD 1.34B 253M 2025-09


DBV Technologies Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.